03 · What You Need to Know
Immediate care and research-safety classification are separate tasks
Do not wait for causality before responding
A participant does not need to prove that the study caused an illness or injury before the research team responds to an immediate safety need.
The event may later turn out to be related to the intervention, related to another research procedure, caused by an underlying medical condition, or completely unrelated to the study. That distinction matters for subsequent safety assessment and responsibility, but it should not delay necessary first aid, clinical evaluation, emergency response, or other actions required by the situation.
This follows directly from the broader distinction between an adverse event and causal attribution. An unfavorable occurrence can require attention before its cause is known.
Stop the research procedure when continuing could worsen the situation
If illness or injury develops during an intervention, examination, interview, exercise task, blood collection, imaging procedure, or other research activity, continuing solely to complete the procedure may expose the participant to additional risk.
The team should follow protocol-defined stopping criteria and clinical or emergency procedures appropriate to the event. The exact response will differ substantially between a minor superficial injury and a potentially life-threatening medical event.
Recognize
Identify that the participant is ill, injured, or experiencing a potentially important change in condition.
Stop or secure
Pause the research activity and remove or control immediate hazards when this can be done safely.
Assess and respond
Use appropriately trained personnel and the study's emergency or medical procedures to determine what immediate assistance is needed.
Escalate
Obtain emergency or professional medical assistance when the participant's condition requires it.
Document and classify
After immediate safety needs are addressed, record the occurrence and complete the required research-safety assessment.
Follow up
Track the participant's outcome and complete required reporting, referrals, treatment arrangements, or other study obligations.
The researcher's role depends on their training and the study setting
A physician-investigator conducting a clinical trial in a hospital has different capabilities from a social researcher conducting an interview in a community setting. The obligation to protect participants does not mean every researcher should attempt to provide medical treatment personally.
Research staff should act within their competence and follow the study's response plan. Depending on the setting, this might involve trained first aid, calling emergency services, alerting an on-site clinical team, contacting a study physician, arranging evaluation, or following another approved pathway.
Watch Out
Do not improvise medical treatment outside your qualifications simply because the illness or injury occurred during your study. Participant protection includes recognizing when the appropriate action is to obtain qualified medical assistance.
An illness or injury can be an adverse event without being research-related
OHRP's broad definition of an adverse event includes an unfavorable medical occurrence temporally associated with research participation whether or not it is considered related to participation. An AE may result from research procedures, the participant's underlying disease or condition, or circumstances unrelated to either.
A participant who develops influenza during a long study may therefore present a very different causal question from someone who experiences bleeding after a research biopsy. Both occurrences may require study documentation under the applicable protocol even though their relationship to the research differs substantially.
Research procedures other than the main intervention can cause injury
Researchers should not restrict causal assessment to the investigational product or principal intervention. Harm may arise from blood draws, biopsies, positioning, exercise testing, imaging, study equipment, changes to usual treatment, transportation arranged by the study, or other research-specific procedures.
The relevant question is whether research participation or a research procedure caused or contributed to the event. The more detailed assessment of adverse-event relatedness should use the framework specified by the study.
Determine whether the event meets serious adverse event criteria
Once the participant's immediate needs are addressed, determine whether the event meets applicable serious adverse event criteria.
Standard clinical-trial frameworks classify events as serious based on outcomes such as death, immediate risk of death, inpatient hospitalization or prolongation of hospitalization, significant disability or incapacity, congenital anomaly or birth defect, or other medically important events meeting the applicable definition.
Seriousness is not the same as severity. A painful injury can be severe without meeting an SAE criterion, while an event requiring hospitalization may qualify as serious even if its symptoms were not initially described as severe.
Do not assume every illness or injury is an unanticipated problem
An event can be an AE or SAE without satisfying the criteria for an unanticipated problem. Under OHRP's framework, an unanticipated problem must be unexpected, related or possibly related to the research, and suggest that the research places participants or others at greater risk of harm than previously known or recognized.
Conversely, an incident can reveal an important new safety risk even when the participant escapes injury. The classifications answer different questions and should not be used interchangeably.
Document what happened while the information is still recoverable
Safety documentation should be factual and sufficiently detailed to support later assessment. Depending on the protocol, relevant information may include when the event began, what the participant was doing, signs and symptoms, research procedures or interventions immediately preceding it, actions taken, medical care obtained, outcome, and information relevant to seriousness and causality.
Avoid replacing observation with conclusion. “Participant became pale, reported dizziness, and lost consciousness for approximately 20 seconds during venipuncture” is more useful for subsequent assessment than “participant had a study-related reaction,” which prematurely embeds a causal judgment.
Follow-up may matter even after the participant leaves
Some events resolve immediately. Others require medical evaluation, hospitalization, continued monitoring, or later diagnostic information.
Research-safety assessment should therefore not necessarily end when the visit ends. Follow the participant's outcome as required by the protocol and applicable safety framework, and update reports when relevant new information becomes available.
Know in advance what treatment or compensation information participants have been given
When research involves more than minimal risk, applicable consent requirements may require information concerning compensation and medical treatments available if injury occurs, including what they consist of or where further information can be obtained. In U.S. HHS-regulated research, this appears among the additional consent elements required when the research involves more than minimal risk.
The existence and extent of treatment or compensation are not universal. They can depend on jurisdiction, institution, sponsor, insurance arrangements, and study. Researchers should therefore know what was promised and what participants were told about treatment or compensation for research-related harm.
The event may expose a problem larger than the individual case
An isolated fall may be accidental. Several participants falling from the same research platform suggests something different. A single episode of fainting after blood collection may be familiar; an unexpectedly high pattern associated with a new procedure may require broader review.
Researchers should consider whether the event reveals a hazard that could affect future participants. If so, immediate corrective measures may be necessary while the study's oversight processes determine whether changes to the entire study are required.
04 · A Practical Example
A participant faints during a research blood draw
Hypothetical Example
The event happens before anyone knows why
During a protocol-required blood draw, a participant reports dizziness, becomes pale, and briefly loses consciousness. The research team does not yet know whether this is a vasovagal reaction, another medical problem, or an event influenced by additional factors.
Stop the procedure
The blood draw is discontinued and the team follows the approved immediate-safety procedure.
Address the participant
Appropriately trained personnel assess the participant and obtain additional medical assistance if indicated.
Document the facts
The team records the timing, observed signs, reported symptoms, research procedure, actions taken, recovery, and other protocol-required information.
Classify the event
The appropriate investigator assesses whether the event meets the AE definition, whether any seriousness criterion applies, and whether the blood draw or another research factor contributed.
Report when required
The team follows the protocol and applicable sponsor, IRB or REC, institutional, and regulatory requirements.
Review prevention
If similar events recur or the procedure appears to carry greater risk than expected, the team reassesses whether additional safeguards are needed.
At no point does the participant need to wait for the research team to settle causality before receiving the immediate response required by their condition.
07 · A Quick Checklist
When a participant becomes ill or injured
During and after the event, verify:
The research activity has been stopped or modified when continuing could increase risk.
Immediate first aid, medical evaluation, or emergency assistance has been obtained as appropriate.
Research staff have stayed within their training and professional competence.
The factual circumstances, actions taken, and participant outcome have been documented according to the protocol.
The event has been assessed for AE and SAE classification using the applicable definitions.
Relatedness and expectedness have been assessed separately from seriousness.
Required sponsor, IRB or REC, institutional, and regulatory notifications have been identified and completed on time.
Necessary follow-up information and participant outcome will continue to be collected as required.
The team has considered whether the event reveals a hazard requiring protection of other participants or modification of the study.
